- Copy top eToro investors automatically with CopyTrader
- Trade stocks, options, ETFs and crypto in one app
- Use a demo account to practice before investing
- See how top investors build their portfolios
Intrinsic Medicine, which develops treatments for gut-related conditions using synthetic biology-manufactured human identical milk oligosaccharide (HiMO) molecules, has cancelled plans to go public in the US. Learn more about the withdrawn IPO, and find out about similar companies in which you can invest.
On July 25, 2022, Intrinsic Medicine announced it was cancelling its plans to go public. Originally, it had planned to conduct an IPO on the Nasdaq under the ticker symbol “INRX.” Altogether, the company had planned to raise around $25 million by offering 4.2 million stocks at a price of $5.00 – $7.00.
Spartan Capital Securities, LLC was slated to act as the lead underwriter of the deal. You can read more about the IPO in this prospectus submitted to the US Securities and Exchange Commission (SEC) on May 4, 2022.
Current market conditions have been cited as the reason for for the cancellation. A future IPO date has not been announced.
Even though you won’t be able to buy Intrinsic Medicine stock, you can still invest in other biotechnology companies that develop treatments for gut-related conditions.
| Company | Stock info |
|---|---|
| Finch Therapeutics Group | NasdaqGS: FNCH |
| Seres Therapeutics | NasdaqGS: MCRB |
| Evelo Biosciences | NasdaqGS: EVLO |
| PureTech Health | NasdaqGM: PRTC |
You’ll need a brokerage account to buy and sell stocks. Here’s how it works:
The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on eight different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.
We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Everything we know about the Robinhood Ventures Fund II IPO, plus information on how to buy in.
SoFi, Robinhood, Tastytrade, Webull, Interactive Brokers, E*TRADE, eToro and others top our list for the best options trading platforms.
Learn about stock analysis and how to use it to find the right company to buy.
Our experts reviewed 25+ services to find the 7 best stock picking platforms of 2026.
Learn how to read a stock chart to make educated and informed investment decisions.
Balance your portfolio and maximize returns with these tips.
Risks and performance indicators to consider before you buy into a SPAC.
Top stocks and ETFs to consider for those ready to invest in cannabis.
Learn about each of the five main asset classes and understand why it’s important to diversify your money across several of them.
Here’s what a blue chip stock is, including examples, as well as what makes it attractive to investors and how to buy and sell them.